Contribution of transplanted bone marrow has, in many models, led to the appearance of marrow-derived epithelial cells in a variety of organs, including the lung. Following the initial descriptions of these cells, many questions remain about the mechanisms by which bone marrow adopts an epithelial phenotype in the murine lung. Data from other epithelial lineages, such as those of the kidney and colon, suggest that one mechanism is fusion of transplanted marrow with host pneumocytes. This process appears to require severe damage and may not be the only mechanism by which mature lung epithelia can derive from marrow. This article discusses the processes leading to the appearance of marrow-derived pneumocytes and highlights the therapeutic potential of bone marrow to fuse with or differentiate into epithelial cells of the lung.
Keywords: Bone marrow; stem cell plasticityWe and others have demonstrated that bone marrow-derived cells (BMDCs) can develop into epithelial cells in the lung, liver, gastrointestinal (GI) tract, and skin. These findings, initially reported in laboratory animals, have also been reported in humans. It is not yet clear which subpopulation(s) of the bone marrow (BM) has the ability to become epithelial cells. Another unresolved question regarding this BM to epithelial transition is the mechanism by which this occurs. Data suggest that cell-cell fusion can occur but is not required. We hypothesize that both the degree of epithelial engraftment and the mechanism by which this occurs in the lung are dependent on the degree and type of damage induced. Here, we review the data regarding the mechanisms underlying the BM to epithelial transition with an emphasis on the role of cell fusion. In addition, we present data regarding the feasibility of using BM cells as a vehicle to deliver gene therapy to the lung.
BM CELLS CAN DEVELOP INTO EPITHELIAL CELLS IN MICEIn the earliest studies demonstrating marrow-derived epithelial cells, Petersen and colleagues (1) and Theise and coworkers (2) showed that female rats and mice that had been lethally irradiated and transplanted with male BM developed Y chromosomepositive hepatocytes. These data were obtained by other laboratories as well, and the reported level of engraftment varied widely, from 0.01 to 2%. This is likely due to multiple variables, including the degree and type of injury induced in the liver, the cell population transplanted, and the method of detection used. BMDCs have also been reported to take on the gene expression